Novo Nordisk Restructures to Focus on Obesity and Diabetes Treatments
Novo Nordisk, a leading pharmaceutical company, is making big changes to focus more on obesity and diabetes treatments. Their CEO […]
Browsing author
Novo Nordisk, a leading pharmaceutical company, is making big changes to focus more on obesity and diabetes treatments. Their CEO […]
A new monitoring system has been developed to enhance quality testing during the production of pharmaceutical tablets. This innovation could […]
Merck & Co (also known as MSD outside the US) has decided to cancel its plans for a £1 billion […]
US-based biotech company LB Pharmaceuticals has successfully raised significant funds through an initial public offering (IPO), breaking a dry spell […]
Lundbeck, a pharmaceutical company, shared new research about eptinezumab at the 2025 International Headache Congress in São Paulo. The data […]
A team of researchers in Japan has developed a new way to check the quality of medicine tablets as they […]
Eisai and Biogen have received FDA approval for LEQEMBI IQLIK (lecanemab-irmb), a new autoinjector for maintaining treatment in early Alzheimer’s […]
Otello Stampacchia, a seasoned biotech investor, has seen the industry face many tough times over the past 20 years. He […]
A new pharmaceutical startup called Braveheart Bio has just acquired the rights to a promising heart medication originally developed in […]
A debate between Stealth BioTherapeutics and the FDA over a drug for Barth syndrome—a rare, often fatal childhood disease—could set […]